Author

A. B. Siva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Dutta· 1 shared A. P. Mishra· 1 shared B. J. Lakshmi· 1 shared B. Varma· 1 shared C. Gurunathan· 1 shared D. T. Sowpati· 1 shared H. Kaur· 1 shared K. B. Tallapaka· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Dutta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Composition of nasopharyngeal microbiota in individuals with SARS-CoV-2 infection across three COVID-19 waves in India

T. Bose, Wasimuddin, V. Acharya, N. K. Pinna, H. Kaur, M. Ranjan, S. Jandhyala, T. Nagabandi, B. Varma, K. B. Tallapaka, D. T. Sowpati, M. M. Haque, A. Dutta, A. B. Siva, S. S. Mande

This study examines nasopharyngeal microbiota changes in SARS-CoV-2 infected individuals across three waves in India, finding consistent depletion of Rickettsiaceae and increased abundance of certain genera in symptomatic patients.

bioRxiv · Jan 2, 2023 · PreprintMicrobiology

Impaired liver regeneration and lipid homeostasis in CCl4 treated WDR13 deficient mice

A. P. Mishra, A. B. Siva, C. Gurunathan, K. Yedella, B. J. Lakshmi

This study shows that Wdr13-deficient mice exhibit impaired liver regeneration and hypertriglyceridemia after CCl4 treatment, linked to PPAR pathway activation.

bioRxiv · Sep 9, 2019Pharmacology & Toxicology